EPS Bio Technology Corp.(TW:4183)
NT$14.500.00 (0.00%)
TW:4183
EPS Bio Technology Corp. financials statements
NT$14.50
At close:0.00 (0.00%)
EPS Bio Technology Corp. (4183) Financial Statements
EPS Bio Technology Corp. Financial Overview
EPS Bio Technology Corp.'s market cap is currently NT$345.10M. The company's EPS TTM is NT$-0.42; its P/E ratio is -13.92; and it has a dividend yield of 4.62%. EPS Bio Technology Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 499.70M | NT$ 451.08M | NT$ 470.17M | NT$ 463.45M | NT$ 480.28M |
| Gross Profit | NT$ 81.93M | NT$ 96.27M | NT$ 115.71M | NT$ 107.42M | NT$ 120.67M |
| Operating Income | NT$ -9.10M | NT$ 3.51M | NT$ 24.92M | NT$ 32.20M | NT$ 26.91M |
| EBITDA | NT$ 6.29M | NT$ 34.46M | NT$ 44.09M | NT$ 49.50M | NT$ 45.49M |
| Net Income | NT$ -7.87M | NT$ 17.31M | NT$ 20.99M | NT$ 25.36M | NT$ 18.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 123.08M | NT$ 128.94M | NT$ 195.29M | NT$ 178.66M | NT$ 203.42M |
| Total Assets | NT$ 533.25M | NT$ 541.89M | NT$ 543.16M | NT$ 527.76M | NT$ 577.45M |
| Total Debt | NT$ 140.75M | NT$ 110.14M | NT$ 115.81M | NT$ 121.40M | NT$ 126.47M |
| Net Debt | NT$ 17.67M | NT$ -18.80M | NT$ -79.47M | NT$ -57.26M | NT$ -76.95M |
| Total Liabilities | NT$ 252.14M | NT$ 237.34M | NT$ 237.13M | NT$ 219.41M | NT$ 278.18M |
| Stockholders' Equity | NT$ 281.11M | NT$ 304.55M | NT$ 306.04M | NT$ 308.36M | NT$ 299.27M |
| Cash Flow | |||||
| Free Cash Flow | NT$ -21.76M | NT$ -46.75M | NT$ 45.69M | NT$ -9.96M | NT$ 19.95M |
| Operating Cash Flow | NT$ 603.00K | NT$ -32.34M | NT$ 55.17M | NT$ 5.00M | NT$ 32.08M |
| Investing Cash Flow | NT$ -23.97M | NT$ -14.40M | NT$ -9.48M | NT$ -14.92M | NT$ -12.14M |
| Financing Cash Flow | NT$ 18.00M | NT$ -24.72M | NT$ -28.91M | NT$ -22.59M | NT$ -34.02M |
Currency in TWD
